Androgen insensitivity syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(21 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Androgen insensitivity syndrome}}
{{CMG}}: {{AE}} {{ARK}}
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
{{SK}} Androgen resistance syndrome; complete androgen insensitivity; Goldberg-Morris syndrome; testicular feminization syndrome; incomplete androgen insensitivity; partial androgen insensitivity; Reifenstein syndrome; Gilbert-Dreyfus syndrome; disorder of sex development; DSD; androgen receptor; hormone replacement therapy; androgen insensitivity; androgen receptor; CAIS; complete androgen insensitivity syndrome; PAIS; partial androgen insensitivity syndrome; MAIS; mild androgen insensitivity syndrome.
{{Infobox_Disease |
{{Infobox_Disease |
   Name          = Androgen insensitivity syndrome |
   Name          = Androgen insensitivity syndrome |
Line 16: Line 23:
   MeshID        = D013734 |
   MeshID        = D013734 |
}}
}}
{{Androgen insensitivity syndrome}}
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''
{{CMG}}
{{SK}} Androgen resistance syndrome; complete androgen insensitivity; Goldberg-Morris syndrome; testicular feminization syndrome; incomplete androgen insensitivity; partial androgen insensitivity; Reifenstein syndrome; Gilbert-Dreyfus syndrome


==[[Androgen insensitivity syndrome overview|Overview]]==
==[[Androgen insensitivity syndrome overview|Overview]]==


==[[Androgen insensitivity syndrome historical perspective|Historical Perspective]]==
==[[Androgen insensitivity syndrome historical perspective|Historical Perspective]]==
==[[Androgen insensitivity syndrome classification|Classification]]==


==[[Androgen insensitivity syndrome pathophysiology|Pathophysiology]]==
==[[Androgen insensitivity syndrome pathophysiology|Pathophysiology]]==
==[[Androgen insensitivity syndrome causes|Causes]]==


==[[Androgen insensitivity syndrome differential diagnosis|Differentiating Androgen insensitivity syndrome from other Diseases]]==
==[[Androgen insensitivity syndrome differential diagnosis|Differentiating Androgen insensitivity syndrome from other Diseases]]==
Line 41: Line 45:


==Diagnosis==
==Diagnosis==
[[Androgen insensitivity syndrome history and symptoms| History and Symptoms]] | [[Androgen insensitivity syndrome physical examination | Physical Examination]] | [[Androgen insensitivity syndrome laboratory findings|Laboratory Findings]] | [[Androgen insensitivity syndrome CT|CT]] | [[Androgen insensitivity syndrome ultrasound|Ultrasound]] | [[Androgen insensitivity syndrome other imaging findings|Other Imaging Findings]] | [[Androgen insensitivity syndrome other diagnostic studies|Other Diagnostic Studies]]
[[Androgen insensitivity syndrome history and symptoms| History and Symptoms]] | [[Androgen insensitivity syndrome physical examination | Physical Examination]] | [[Androgen insensitivity syndrome laboratory findings|Laboratory Findings]] | [[Androgen insensitivity syndrome electrocardiogram|Electrocardiogram]] | [[Androgen insensitivity syndrome x ray|X Ray]] | [[Androgen insensitivity syndrome CT|CT]] | [[Androgen insensitivity syndrome MRI|MRI]] | [[Androgen insensitivity syndrome ultrasound|Ultrasound]] | [[Androgen insensitivity syndrome other imaging findings|Other Imaging Findings]] | [[Androgen insensitivity syndrome other diagnostic studies|Other Diagnostic Studies]]


==Treatment==
==Treatment==
Line 47: Line 51:


==Case Studies==
==Case Studies==
[[Androgen insensitivity syndrome case study one|Case #1]]
[[Androgen insensitivity syndrome case study one|Case #1]]


==Related Chapters==
==Related Chapters==
* 17-hydroxylase deficiency syndrome
* [[17 alpha-hydroxylase deficiency]]
* 3-beta-hydroxysteroid dehydrogenase deficiency
* [[3 beta-hydroxysteroid dehydrogenase deficiency]]
* [[5-alpha-reductase deficiency]]
* [[5-alpha-reductase deficiency]]
* [[Congenital adrenal hyperplasia]]
* [[congenital lipoid adrenal hyperplasia]]
* Mayer-rokitansky syndrome
* [[Rokitansky syndrome|Mayer-rokitansky syndrome]]
 


==References==
{{reflist|2}}


{{GeneTests|androgen}}
{{GeneTests|androgen}}
Line 63: Line 67:
{{Endocrine pathology}}
{{Endocrine pathology}}


[[Category:Genetic disorders]]
[[Category:Intersexuality]]
[[Category:Syndromes]]
[[Category:Genetic Disease]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Mature chapter]]


[[de:Komplette Androgenresistenz]]
[[de:Komplette Androgenresistenz]]

Latest revision as of 23:22, 23 August 2017

Androgen insensitivity syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Androgen insensitivity syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Androgen insensitivity syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Androgen insensitivity syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Androgen insensitivity syndrome

CDC on Androgen insensitivity syndrome

Androgen insensitivity syndrome in the news

Blogs on Androgen insensitivity syndrome

Directions to Hospitals Treating Androgen insensitivity syndrome

Risk calculators and risk factors for Androgen insensitivity syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]: Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]

For patient information click here

Synonyms and keywords: Androgen resistance syndrome; complete androgen insensitivity; Goldberg-Morris syndrome; testicular feminization syndrome; incomplete androgen insensitivity; partial androgen insensitivity; Reifenstein syndrome; Gilbert-Dreyfus syndrome; disorder of sex development; DSD; androgen receptor; hormone replacement therapy; androgen insensitivity; androgen receptor; CAIS; complete androgen insensitivity syndrome; PAIS; partial androgen insensitivity syndrome; MAIS; mild androgen insensitivity syndrome.

Androgen insensitivity syndrome
Testosterone (structure pictured) and dihydrotestosterone to a lesser degree, are the primary androgens involved in AIS.
ICD-10 E34.5
ICD-9 259.5
OMIM 312300 300068
DiseasesDB 29662 Template:DiseasesDB2
MeSH D013734

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Androgen insensitivity syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case #1

Related Chapters

References

androgen at NIH/UW GeneTests

de:Komplette Androgenresistenz it:Sindrome di Morris


Template:WikiDoc Sources